$CVSI News

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

CV Sciences Inc (CVSI) (Q2 2026) Earnings Call Highlights: Strategic Pivot to PlusHealth Amid ...

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) Q2 2026 Earnings Call Transcript

CV Sciences Q2 2026 Earnings Call Transcript

CV Sciences Q2 Adj. EPS $0.00, Sales $2.985M Down From $3.620M YoY

CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026

CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging

CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript

CV Sciences Inc (CVSI) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript

CV Sciences Reports Q1 2026 Results: Full Earnings Call Transcript

CV Sciences Q1 Sales $3.195M Down From $3.606M YoY

CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026

CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results

CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript

CV Sciences Q4 Sales $3.307M Down From $3.884M YoY.

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026